Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?

Future Microbiology

Volumn 10, Issue 4, 2015, Pages 517-526

  Barros, Amanda F ^a   Borges, Natália A ^a   Ferreira, Dennis C ^b   Carmo, Flávia L ^b   Rosado, Alexandre S ^b   Fouque, Denis ^c   Mafra, Denise ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

cardiovascular diseases; chronic renal failure; gut microbiota; inflammation; oxidative stress

Indexed keywords

ADULT; AGED; ARTICLE; BUTYRIVIBRIO; BUTYRIVIBRIO CROSSOTUS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; FEMALE; FLAVOBACTERIACEAE; HUMAN; INFLAMMATION; INTESTINE FLORA; LACHNOSPIRACEAE; LISTERIA MONOCYTOGENES; MALE; MICROBIAL COMMUNITY; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PRIORITY JOURNAL; BIOTA; BLOOD ANALYSIS; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; GASTROINTESTINAL TRACT; MICROBIOLOGY; RISK ASSESSMENT;

BACTERIA (MICROORGANISMS); BUTYRIVIBRIO CROSSOTUS; FLAVOBACTERIACEAE; LACHNOSPIRACEAE; LISTERIA MONOCYTOGENES;

BIOTA; BLOOD CHEMICAL ANALYSIS; CARDIOVASCULAR DISEASES; DENATURING GRADIENT GEL ELECTROPHORESIS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEQUENCE ANALYSIS, DNA;

EID: 84927757224     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.14.140     Document Type: Article

References (45)

1. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int. 73, 1174-1180 (2008).
2. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 62, 361-380 (2011).
3. Mafra D, Lobo JC, Barros AF, Koppe L, Vaziri ND, Fouque D. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in CKD. Future Microbiol. 9, 399-410 (2014).
4. Methé BA, Nelson KE, Pop M et al. A framework for human microbiome research. Nature 486(7402), 215-221 (2012).
5. Nita HS. Microbiota-immune system interaction: an uneasy alliance. Curr. Opin. Microbiol. 14(1), 99-105 (2011).
6. Moreira AP, Texeira TF, Ferreira AB, Peluzio MC, Alfenas GC. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br. J. Nutr. 108(5), 801-809 (2012).
7. Mafra D, Barros AF, Fouque D. Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients. Future Microbiol. 8, 1317-1323 (2013).
8. Szeto CC, Kwan BCH, Chow KM et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol. 3(2), 431-436 (2008).
9. Vaziri ND, Wong J, Pahl MV et al. Chronic kidney disease alters the composition of intestinal microbial flora. Kidney Int. 83(2), 308-315 (2012).
10. Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am. J. Clin. Nutr. 36(4), 680-690 (1982).
11. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am. J. Clin. Nutr. 34(11), 2540-2545 (1981).
12. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skin-fold thickness: measurements on men and women aged from 16 to 72 years. Br. J. Nutr. 32(1), 77-97 (1974).
13. Siri WE. Body composition from fluid space and density. In: Techniques for Measuring Body Composition. Brozek J, Hanschel A (Eds). National Academy of Science, Washington, DC, USA, 223-224 (1961).
14. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics, IL, USA, 90 (1991).
15. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organization. WHO Technical Report Series, Geneva, Switzerland, 894 (2000).
16. Valdez R. A simple model-based index of abdominal adiposity. J. Clin. Epidemiol. 44(9), 955-956 (1991).
17. Ikemoto M, Tanaka T, Takai Y et al. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin. Chem. 49(4), 594-600 (2003).
18. Heuer H, Smalla K. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel biological sequence electrophoresis for studying soil microbial communities. In: Modern Soil Microbiology. Elsas JD, Trevors, , Wellington EMH (Eds). Marcel Dekker, NY, USA, 353-373 (1997).
19. Carmo FL, Santos HF, Martins EF, Elsas JDV, Rosado AS, Peixoto RS. Bacterial structure and characterization of plant growth promoting and oil degrading bacteria from the rhizospheres of mangrove plants. J. Microbiol. 49, 4 (2011).
20. Hall TA. BioEdit: a user-friendly alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41, 95-98 (1999).
21. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
22. Ledder RG, Gilbert P, Huws SA et al. Molecular analysis of the subgingival microbiota in health and disease. Appl. Environ. Microbiol. 73(2), 516-523 (2007).
23. Strathdee F, Free A. Denaturing Gradient Gel Electrophoresis (DGGE). Methods Mol. Biol. 1054, 145-157 (2013).
24. Siqueira JF Jr., Rǒças IN, Rosado AS. Investigation of bacterial communities associated with asymptomatic and symptomatic endodontic infections by denaturing gradient gel electrophoresis fingerprinting approach. Oral Microbiol. Immunol. 19, 363-369 (2004).
25. Machado de Oliveira JC, Gama TG, Siqueira JF Jr., Rǒças IN, Peixoto RS, Rosado AS. On the use of denaturing gradient gel electrophoresis approach for bacterial identification in endodontic infections. Clin. Oral Investig. 11(2), 127-132 (2007).
26. Machado de Oliveira JC, Siqueira JF Jr., Rǒças IN et al. Bacterial community profiles of endodontic abscesses from Brazilian and USA subjects as compared by denaturing gradient gel electrophoresis analysis. Oral Microbiol. Immunol. 22(1), 14-18 (2007).
27. Siqueira JF, Rǒças IN. Exploração de métodos moleculares para explorar infecções endodǒnticas: Parte 1-tecnologias moleculares atuais para diagnóstico microbiológico. J. Endod. 31, 411-423 (2005).
28. Muyzer G, Smalla K. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie Van Leeuwenhoek. 73(1), 127-141 (1998).
29. Wu X, Ma C, Han L et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61(1), 69-78 (2012).
30. Rea MC, O'Sullivan O, Shanahan F et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J. Clin. Microbiol. 50(3), 867-875 (2012).
31. Schuppler M, Loessner MJ. The opportunistic pathogen listeria monocytogenes: pathogenicity and Interaction with the mucosal immune system. Int. J. Inflam. 2010, 12 (2010).
32. Lambert GP. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J. Anim. Sci. 87(14), 101-108 (2009).
33. Hauser AB, Stinghen AEM, Gonçalves SM, Bucharles S, Pecoits-filho RA. Gut feeling on endotoxemia: causes and consequences in chronic kidney disease. Nephron Clin. Pract. 118, 165-172 (2011).
34. Ritz E. Intestinal-renal syndrome: mirage or reality Blood Purif. 31(1-3), 70-76 (2011).
35. Zak-Gob A, Koceak P, Aptekorz M et al. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int. J. Endocrinol. 2013, 9 (2013).
36. Biagi E, Nylund L, Candela M et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5(5), e10667 (2010).
37. Kim JH, Yoon YJ, Lee J et al. Outer membrane vesicles derived from Escherichia coli up-regulate expression of endothelial cell adhesion molecules in vitro and in vivo. PLoS ONE 8(3), e59276 (2013).
38. Schepers E, Meer TN, Glorieux G, Goeman J, Van der Eycken J, Vanholder R. p-Cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol. Dial. Transplant. 22(2), 592-596 (2007).
39. Spoto B, Leonardis D, Parlongo RM et al. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. Nutr. Metab. Cardiovasc. Dis. 22(11), 981-988 (2011).
40. Barros AF, Moraes C, Pinto MB, Lobo JC, Mafra D. Is there association between acyl-ghrelin and inflammation in hemodialysis patients J. Bras. Nefrol. 35(2), 120-126 (2013).
41. Malíková K, Brodská H, Lachmanová J et al. Plasma calprotectin in chronically dialyzed end-stage renal disease patients. Inflamm. Res. 59(4), 299-305 (2010).
42. Cholidou KG, Kostakis ID, Manali ED et al. Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea. Cytokine 61(3), 917-923 (2013).
43. Boon N, Windt W, Verstraete W, Top EM. Evaluation of nested PCR-DGGE (denaturing gradient gel electrophoresis) with group-specific 16S rRNA primers for the analysis of bacterial communities from different wastewater treatment plants. FEMS Microbiol. Ecol. 39(2), 101-112 (2002).
44. Ranganathan N, Patel B, Ranganathan P et al. Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats. Scientific World J. 24(5), 652-660 (2005).
45. Ranganathan N, Ranganathan P, Friedman EA et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv. Ther. 27(9), 634-647 (2010).